-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver injury, with studies showing that 32-37% of patients develop fibrosis over a 3-6 year period, and up to 12% of cases in 8- Cirrhosis developed over a 10-year peri.
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver injury, with studies showing that 32-37% of patients develop fibrosis over a 3-6 year period, and up to 12% of cases in 8- Cirrhosis developed over a 10-year peri.
statistics
The results showed that the total fecal BA concentration in the NAFLD group was significantly higher than that in the HC group, and the degree of fibrosis worsening was significantly increas.
This study demonstrated that NAFLD patients had higher fecal and serum BA and C4 concentrations with a risk of worsening fibrosis, suggesting that abnormal BA metabolism is associated with NAFLD fibrosis progressi.
This study demonstrated that NAFLD patients had higher fecal and serum BA and C4 concentrations with a risk of worsening fibrosis, suggesting that abnormal BA metabolism is associated with NAFLD fibrosis progressi.
Original source:
Kasai, Yu.
Kasai, Yu.
Et .
Association of serum and fecal bile acid patterns with liver fibrosis in biopsy-proven nonalcoholic fatty liver disease: An observational stu.
Clinical and Translational Gastroenterolo.
202 Association of serum and fecal bile acid patterns with liver fibrosis in biopsy-proven nonalcoholic fatty liver disease: An observational stu.
Leave a comment here
